Biomarkers such as ring sideroblasts are indicators for response to treatments like luspatercept (Reblozyl). In patients with ...

A systematic review and meta-analysis found no clear advantage for automated red cell exchange. For patients with sickle cell disease (SCD), exchange transfusion has benefits over simple transfusion ...

Blood transfusion therapy remains an indispensable intervention in the management of sickle cell disease (SCD), mitigating life‐threatening complications such as vaso‐occlusive crises and stroke. The ...

The Transfusion Medicine Updates Conference concluded Saturday evening, in Abu Dhabi, drawing broad participation from physicians and specialists in transfusion medicine, laboratory sciences and ...